Comparison of lipid and detergent enzyme environments for identifying inhibitors of membrane-bound energy-transducing proteins
Section snippets
Author contributions
E.D., G.M.C. and A.H. designed the research, E.D. performed the research, E.D., G.M.C. and A.H. analysed the data and E.D., G.M.C. and A.H. wrote the paper.
Declaration of conflicting interests
The authors declare no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Acknowledgements and funding
This work was supported by the Health Research Council of New Zealand and the Maurice Wilkins Centre for Molecular Biodiscovery. E. Dunn was funded by research scholarships from the University of Otago and The Todd Foundation New Zealand. We thank Ivan Summit for equipment use, and Dr. Mattie Timmer and Dr. Bridget Stocker for the Quinolinequinone Library.
References (15)
- et al.
A high-throughput screening assay for identification of inhibitors of the A1AO-ATP synthase of the rumen methanogen Methanobrevibacter ruminantium M1
J. Microbiol. Methods
(2015) Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
Tuberculosis (Edinb.)
(2013)- et al.
The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides
Cryobiology
(2009) - et al.
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Adv. Drug Deliv. Rev.
(1997) - et al.
Perspective: challenges and opportunities in TB drug discovery from phenotypic screening
Bioorg. Med. Chem.
(2015) - et al.
The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones
Bioorg. Med. Chem.
(2010) - et al.
A simple statistical parameter for use in evaluation and validation of high throughput screening assays
J. Biomol. Screen.
(1999)
Cited by (5)
A simple assay for inhibitors of mycobacterial oxidative phosphorylation
2024, Journal of Biological ChemistryBiochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate:quinone oxidoreductase, a potential drug target
2018, Biochimica et Biophysica Acta - BioenergeticsCitation Excerpt :Screening of several ETC inhibitors and antiparasitic agents were conducted against recombinant PfMQO. A similar screening system using PfNDH2-bound membranes (not purified enzyme) has been previously shown to be advantageous during HTS by removing hits that are less potent and less amenable to drug development [72]. Due to pH instability of some compounds, the screening was performed at neutral pH, in which the PfMQO still retained > 90% of its activity.
Annotated compound data for modulators of detergent-solubilised or lipid-reconstituted respiratory type II NADH dehydrogenase activity obtained by compound library screening
2016, Data in BriefCitation Excerpt :The table contains the library; compound name, number of H-bond donors/acceptors, molecular weight, lipophilicity (logP) and degree of inhibition/stimulation for DS and LR protein (Table 1). Type II NADH dehydrogenase (NDH-2) was purified and reconstituted into proteoliposomes as described by Dunn et al. [2,3]. Detergent-solubilised (DS) NDH-2 or lipid-reconstituted (LR) NDH-2 were screened by end point 96-well assay (340 nm, Varioskan® Flash Thermo Scientific, in the presence of 100 μM menadione and 20 μM test compound.
Microtiter screening reveals oxygen-dependent antimicrobial activity of natural products against mastitis-causing bacteria
2019, Frontiers in MicrobiologyType-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery
2017, Expert Opinion on Therapeutic Targets